CMOPF (Cosmo NV) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CMOPF Cosmo NV CMOPF
82 GF Score
Price $80.44
GF Value $54.43
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Cosmo NV Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

CMOPF
82GF Score
Cosmo NV CMOPF
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cosmo NV (CMOPF) Overvalued in 2026?

Based on GuruFocus' analysis, Cosmo NV stock appears to be overvalued. The current stock price of $80.44 is trading 47.8% above its estimated GF Value™ of $54.43. GuruFocus considers Cosmo NV to be Significantly Overvalued.

Key valuation signals for CMOPF:

  • Interest Received:
  • GF Value™: $54.43 vs. price of $80.44 (47.8% above fair value)
  • GF Score™: 82/100 with 3 warning signs

No single metric tells the full story. See the CMOPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cosmo NV Business Description

Address 91/94 North Wall Quay, 7th Floor, One North Dock, Dublin, IRL, D01 H7V7
Cosmo NV is is a life sciences company. The company is focused on MedTech AI, dermatology, gastrointestinal diseases, and contract development and manufacturing (CDMO). The company designs, develops, and manufactures solutions to address critical medical needs. Its technologies are trusted by international pharmaceutical and MedTech companies and reach patients and healthcare providers around the world. The product pipeline includes Eleview, GI Genius, Winlevi, Lialda, Uceris, and others.
82GF Score

Get the complete analysis for CMOPF

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$80.44
Price
$54.43
GF Value